Cargando…
Against all odds: anti-IgE for intrinsic asthma?
For many years, pathogenetic concepts and the results of clinical trials supported the view that anti-IgE treatment is specifically effective in allergic asthma. However, there is now growing clinical and mechanistic evidence suggesting that treatment with the anti-IgE antibody omalizumab can be eff...
Autores principales: | Lommatzsch, Marek, Korn, Stephanie, Buhl, Roland, Virchow, Johann Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888607/ https://www.ncbi.nlm.nih.gov/pubmed/23709757 http://dx.doi.org/10.1136/thoraxjnl-2013-203738 |
Ejemplares similares
-
Asthma und Covid-19
por: Buhl, Roland, et al.
Publicado: (2020) -
COVID‐19 in a patient with severe asthma treated with Omalizumab
por: Lommatzsch, Marek, et al.
Publicado: (2020) -
Anti- IgE treatment in asthma: is atopy essential?
por: Gulec, Mustafa, et al.
Publicado: (2015) -
Severe asthma: anti-IgE or anti-IL-5?
por: Papathanassiou, Evgenia, et al.
Publicado: (2016) -
Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010)